1. 2049 AIO-KRK-0109: A randomized phase II trial of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as 1st-line treatment in RAS-wild-type metastatic colorectal cancer (mCRC). (September 2015) Authors: Martens, U.M.; Wessendorf, S.; Knorrenschild, J. Riera; Buechner-Steudel, P.; Florschuetz, A.; Atzpodien, J.; Greeve, J.; Kanzler, S.; Ettrich, T.; Lindig, U.; Egger, M.; Hebart, H.; Geissler, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P647: SAFETY AND EFFECTIVENESS OF VENETOCLAX MONOTHERAPY IN R/R CLL PATIENTS WITH OR WITHOUT RISK-ASSOCIATED GENETIC MARKERS – DATA FROM THE OBSERVATIONAL VERVE STUDY. (23rd June 2022) Authors: Schwaner, I.; Hebart, H.; Losem, C.; Wolff, T.; Famulla, K.; Huelsenbeck, J.; Schmidt, B.; Nösslinger, T.; Rossi, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA. (23rd June 2022) Authors: Stegelmann, F.; Jahn, E.; Koschmieder, S.; Heidel, F.; Hochhaus, A.; Hebart, H.; Isfort, S.; Reiter, A.; Bangerter, M.; Waller, C. F.; Wolleschak, D.; Scheid, C.; Göthert, J.; Schafhausen, P.; Kindler, T.; Radsak, M. P.; Gattermann, N.; Möhle, R.; von Bubnoff, N.; Schrade, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P646: EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH RITUXIMAB (VENR) IN R/R CLL PATIENTS WITH OR WITHOUT RISK-ASSOCIATED GENETIC MARKERS – DATA FROM THE OBSERVATIONAL VERVE STUDY. (23rd June 2022) Authors: Schwaner, I.; Hebart, H.; Losem, C.; Wolff, T.; Famulla, K.; Huelsenbeck, J.; Schmidt, B.; Nösslinger, T.; Rossi, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG). (June 2017) Authors: Cramer, P.; von Tresckow, J.; Bahlo, J.; Robrecht, S.; Al‐Sawaf, O.; Langerbeins, P.; Engelke, A.; Fink, A.M.; Fischer, K.; Seiler, T.; von Weikersthal, L.Fischer; Hebart, H.; Kreuzer, K.A.; Ritgen, M.; Kneba, M.; Wendtner, C.M.; Stilgenbauer, S.; Eichhorst, B.; Hallek, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗